Your browser doesn't support javascript.
loading
Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020.
Nemati, Saeed; Mohebbi, Elham; Toorang, Fatemeh; Hadji, Maryam; Hosseini, Bayan; Saeedi, Elnaz; Abdi, Sepideh; Nahvijou, Azin; Kamangar, Farin; Roshandel, Gholamreza; Ghanbari Motlagh, Ali; Pourshams, Akram; Poustchi, Hossein; Haghdoost, Ali Akbar; Najafi, Farid; Sheikh, Mahdi; Malekzadeh, Reza; Zendehdel, Kazem.
Afiliación
  • Nemati S; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohebbi E; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
  • Toorang F; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Hadji M; Department of Public Health, School of Public Health, Tampere University, Tampere, Finland.
  • Hosseini B; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Saeedi E; International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Abdi S; Biostatistics Research Group, Department of Health Science, University of Leicester, Leicester, UK.
  • Nahvijou A; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Kamangar F; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Roshandel G; Department of Biology, School of Computer, Mathematical and Natural Sciences, Morgan State University, Baltimore, Maryland, USA.
  • Ghanbari Motlagh A; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Pourshams A; Cancer Research Centre, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Poustchi H; Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti Medical University, Tehran, Iran.
  • Haghdoost AA; Digestive Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Najafi F; Digestive Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Sheikh M; Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
  • Malekzadeh R; Department of Epidemiology and Biostatistics, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Zendehdel K; International Agency for Research on Cancer (IARC/WHO), Genomic Epidemiology Branch, Lyon, France.
Int J Cancer ; 153(10): 1758-1765, 2023 11 15.
Article en En | MEDLINE | ID: mdl-37548110
ABSTRACT
In the current study, we aimed to calculate the fraction of cancer attributable to modifiable risk factors in Iran in 2020. Population attributable fractions (PAFs) were calculated for established cancer risk factors using three data sources the national cancer incidence reports, relative risks extracted from global and national meta-analyses, and exposure prevalence from national/subnational population-based surveys. In addition to overall cancers, the PAFs were estimated separately for each cancer site among men and women. Overall, 32.6% of cancers in 2020 in Iran were attributable to known risk factors. The PAF in men (40.2%) was twice as high as in women (21.1%). Cigarette smoking (15.4%), being overweight (5.0%), opium use (3.9%) and H. pylori infection (3.8%) were the leading causes of cancers. For men, the highest PAFs belonged to cigarette smoking (26.3%), opium use (6.8%) and being overweight (3.1%), while for women, the highest PAFs belonged to being overweight (7.2%), H. pylori infection (2.7%) and cigarette smoking (2.7%). Among Iranian men and women, the PAFs of waterpipe smoking were 2% and 0.9%, respectively. A third of incident cancers in Iran are due to modifiable exposures, mainly cigarette smoking, being overweight, and H. pylori infection. Opium consumption and waterpipe smoking collectively accounted for 8.8% of cancer occurrence in men and 1.3% in women in Iran. These emerging risk factors should be taken into consideration in future PAF studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adicción al Opio / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adicción al Opio / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Irán